Kristiina Vuori - Jun 30, 2020 Form 4/A - Amendment Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Jun 30, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/18/2022, 07:26 PM
Date Of Original Report
Jul 2, 2020
Next filing
Jun 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +44.5K $0.00 44.5K Jun 30, 2020 Common Stock 44.5K $0.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
F2 The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.